Brief: Armata Pharmaceuticals Announces $20 Million Investment To Support Advancement Of The Company's Bacteriophage Development Programs
27/01/2021 12:19
Jan 27 (Reuters) - Armata Pharmaceuticals Inc ARMP.A :
* ARMATA PHARMACEUTICALS ANNOUNCES $20 MILLION INVESTMENT TO
SUPPORT ADVANCEMENT OF THE COMPANY'S BACTERIOPHAGE DEVELOPMENT
PROGRAMS
* ARMATA PHARMACEUTICALS - ENTERED AGREEMENT TO SELL CO'S
COMMON
STOCK, WARRANT SECURITIES TO INNOVIVA STRATEGIC OPPORTUNITIES
LLC
* ARMATA PHARMACEUTICALS INC - TO USE NET PROCEEDS FOR
ONGOING
ADVANCEMENT OF ITS BACTERIOPHAGE DEVELOPMENT PROGRAMS
Source text for Eikon: ID:nPnDSN8ra
Further company coverage: ARMP.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles